Form CORRESP - Correspondence:
SEC Accession No. 0001493152-24-014541
Filing Date
2024-04-15
Accepted
2024-04-15 07:00:29
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 14107
2 formcorresp_001.jpg GRAPHIC 11348
  Complete submission text file 0001493152-24-014541.txt   30961
Mailing Address 4475 EXECUTIVE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 4475 EXECUTIVE DRIVE SUITE 200 SAN DIEGO CA 92121 858-794-9600
Calidi Biotherapeutics, Inc. (Filer) CIK: 0001855485 (see all company filings)

EIN.: 862967193 | State of Incorp.: DE | Fiscal Year End: 1231
Type: CORRESP
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)